关注
Han Cong Seow
Han Cong Seow
在 connect.hku.hk 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Inhaled dry powder formulation of tamibarotene, a broad‐spectrum antiviral against respiratory viruses including SARS‐CoV‐2 and influenza virus
Q Liao, S Yuan, J Cao, K Tang, Y Qiu, HC Seow, RCH Man, Z Shao, ...
Advanced Therapeutics 4 (7), 2100059, 2021
202021
Spray-dried and spray-freeze-dried powder formulations of an anti-interleukin-4Rα antibody for pulmonary delivery
HW Pan, HC Seow, JCK Lo, J Guo, L Zhu, SWS Leung, C Zhang, ...
Pharmaceutical Research 39 (9), 2291-2304, 2022
122022
Inhalable neutralizing antibodies–promising approach to combating respiratory viral infections
MYT Chow, HW Pan, HC Seow, JKW Lam
Trends in pharmacological sciences 44 (2), 85-97, 2023
112023
Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration
HC Seow, Q Liao, ATY Lau, SWS Leung, S Yuan, JKW Lam
International Journal of Pharmaceutics 619, 121704, 2022
72022
Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
HC Seow, JP Cai, HW Pan, C Luo, K Wen, J Situ, K Wang, H Cao, ...
Journal of Controlled Release 358, 128-141, 2023
52023
Dual targeting drug delivery strategy for precise medicine: Simultaneous nasal and lung delivery of metallodrug against SARS-CoV 2
S Wang, HC Seow, R Wang, H Li, JKW Lam, H Sun
10th Asian Biological Inorganic Chemistry Conference (28/11/2022-03/12/2022 …, 2022
2022
Development of Inhalable Powder Formulation of Broad-Spectrum Antiviral Agent for Respiratory Viral Infections
Q Liao, HC Seow, S Yuan, JKW Lam
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 34 (3), A4-A5, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–7